数字双胞胎在高吞吐量染色学过程中开发单克隆抗体
Tiago Castanheira Silva1, Michel Eppink2, Marcel Ottens1
1Department of Biotechnology, Delft University of Technology, van der Maasweg 9, Delft, 2629 HZ, the Netherlands.
Journal of chromatography. A
|February 13, 2024
概括
数字双胞胎和高通量过程开发 (HTPD) 加快单克隆抗体 (mAb) 制造. 这种混合方法使用实验和计算方法验证色谱过程,确认收获溶液对树脂性能的影响最小.
科学领域:
- 生物技术是生物技术.
- 化学工程是化学工程的重要组成部分.
- 过程开发 过程开发
背景情况:
- 单克隆抗体 (mAb) 产业日益数字化,数字双胞胎和高通量过程开发 (HTPD) 对于过程验证和创新变得至关重要.
- 研究澄清的细胞培养超 (收获) 成分对树脂吸附的影响至关重要,但研究不足.
研究的目的:
- 提出一种混合的HTPD方法,整合了染色体过程开发的实验,计算和决策阶段.
- 为了研究mAb在收获中对各种蛋白质A树脂的平衡吸附,并将其与纯 mAb实验进行比较.
- 采用Lumped Kinetic Model来建模列色谱,并分析质量转移系数 (kov).
主要方法:
- 确定了13种蛋白A和16种离子交换树脂的平衡吸附等温体,使用纯的mAb.
- 研究了在澄清细胞培养中对蛋白A树脂的mAb吸附 (收获).
- 模拟的柱状染色法用一个块状动力模型来确定总体质量转移系数 (kov).
主要成果:
- 收获溶液成分对mAb对蛋白质A树脂的吸附有微不足道的影响.
- 观察到kov和样本料度之间的线性相关性,与质量转移理论保持一致.
- 混合HTPD方法有效地整合了计算,实验和决策阶段.
结论:
- 介绍的混合HTPD方法加速了染色学过程的开发.
- 开发的白盒数字双胞胎增强了流程理解和验证.
- 这种方法为优化mAb净化过程提供了一个强大的框架.
更多相关视频
07:48A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
22.3K
07:53Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
Published on: August 16, 2019
9.2K
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Affinity Chromatography
641
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
641
